MDGP (Medgroup) YoY EBITDA Growth: 0.00% (As of Dec. 2094)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Medgroup YoY EBITDA Growth?

Medgroup MDGP YoY EBITDA Growth is 0.00% as of Dec. 2094.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Medgroup's YoY EBITDA Growth for the quarter that ended in Dec. 2094 was 0.00%.

Medgroup's EBITDA per Share for the three months ended in Dec. 2094 was $0.06.

Medgroup YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Medgroup's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medgroup YoY EBITDA Growth Chart

Medgroup Annual Data
Trend Mar90 Mar91 Mar92 Mar93 Mar94
YoY EBITDA Growth
0.00 -252.71 82.95 -956.00 137.95

Medgroup Quarterly Data
Mar90 Jun90 Sep90 Dec90 Mar91 Jun91 Sep91 Dec91 Mar92 Jun92 Sep92 Dec92 Mar93 Jun93 Sep93 Dec93 Mar94 Jun94 Sep94 Dec94
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -100.00 113.23 -88.48 0.00 0.00

Medgroup YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Medgroup's YoY EBITDA Growth for the fiscal year that ended in Mar. 2094 is calculated as:

YoY EBITDA Growth (A: Mar. 2094 )
=(EBITDA per Share (A: Mar. 2094 )-EBITDA per Share (A: Mar. 2093 ))/ | EBITDA per Share (A: Mar. 2093 ) |
=(0.501--1.32)/ | -1.32 |
=137.95 %

Medgroup's YoY EBITDA Growth for the quarter that ended in Dec. 2094 is calculated as:

YoY EBITDA Growth (Q: Dec. 2094 )
=(EBITDA per Share (Q: Dec. 2094 )-EBITDA per Share (Q: Dec. 2093 )) / | EBITDA per Share (Q: Dec. 2093 )) |
=(0.056-0)/ | 0 |
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 0.00% mean?
Medgroup (MDGP) has a YoY EBITDA Growth of 0.00% as of Dec. 2094. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Medgroup and its competitors.
Is Medgroup's YoY EBITDA Growth too high?
Medgroup's current YoY EBITDA Growth is 0.00%.
How does Medgroup's YoY EBITDA Growth compare to USNU and ATMS?
Medgroup's YoY EBITDA Growth of 0.00% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Healthcare Providers & Services company?
A good YoY EBITDA Growth depends on the Healthcare Providers & Services industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Medgroup and its competitors. Medgroup's current YoY EBITDA Growth is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medgroup stock overvalued right now?
Medgroup (MDGP) has a current YoY EBITDA Growth of 0.00%. The current YoY EBITDA Growth is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Medgroup (MDGP), the current YoY EBITDA Growth is 0.00% as of Dec. 2094. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medgroup Business Description

Address 4430 Haskell Avenue, Suite 210, Encino, CA, USA, 91436
Medgroup Inc is a multi-specialty health care provider and serves the community with treating injuries and illness. Its facilities have diagnostic testing in computerized ROM, muscle testing, x-ray, EMG/NCV, EKG, laboratory and pharmacy.